An E-platform for Learners

Day: August 27, 2025

Experts Call for Stronger Transparency and Clear Patient Definitions in the 340B Program

Experts Call for Stronger Transparency and Clear Patient Definitions in the 340B Program

Pharm'Up

In an interview, Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, argues...

St. Jude Scientists Discover Midkine Protein’s Protective Role Against Alzheimer’s

St. Jude Scientists Discover Midkine Protein’s Protective Role Against Alzheimer’s

Pharm'Up

In a significant breakthrough for Alzheimer’s research, scientists at St. Jude Children’s Research Hospital have demonstrated for...

New Copper Catalyst Breakthrough Unlocks Indole C5 Position for Drug Development

New Copper Catalyst Breakthrough Unlocks Indole C5 Position for Drug Development

Pharm'Up

Researchers at Chiba University, Japan, have reported a significant breakthrough in synthetic organic chemistry by developing a...

Eris Lifesciences Expands Global Reach with ANVISA Approval for Ahmedabad Facility

Eris Lifesciences Expands Global Reach with ANVISA Approval for Ahmedabad Facility

Pharm'Up

In a significant strategic move, Eris Lifesciences announced that a manufacturing unit at its Ahmedabad campus has...

CuraTeQ Biologics Secures UK Approval for Dazublys, Expanding Oncology Portfolio

CuraTeQ Biologics Secures UK Approval for Dazublys, Expanding Oncology Portfolio

Pharm'Up

In a significant regulatory milestone, CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd.,...

Indian Regulator Recommends Dr. Reddy’s for Olutasidenib Capsules, Waives Phase III Trial

Indian Regulator Recommends Dr. Reddy’s for Olutasidenib Capsules, Waives Phase III Trial

Pharm'Up

In a significant step towards expanding the availability of cancer treatments in India, the Subject Expert Committee...